** Shares of biotech company Neurizon Therapeutics NUZ.AX jump 12.7% to A$0.071, their highest level since May 18

** On track for best day since Jan 23

** Co signs long-term supply agreement with U.S.-listed Elanco Animal Health ELAN.N for an initial term of five years

** Secures access to human health monepantel, the active pharmaceutical ingredient in its lead asset, NUZ-001

** Stock down 16.5% YTD, including moves in current session